News
Guggenheim downgraded Novo Nordisk (NVO) to Neutral from Buy.Stay Ahead of the Market: Discover outperforming stocks and invest smarter with ...
Danish drugmaker Novo Nordisk said on Monday several hundred counterfeit units of its diabetes drug Ozempic were being ...
Novo Nordisk , the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil ...
The tabletop digital frame adds a 12-inch model with a 4:3 aspect ratio to the company’s lineup.
Aura, a digital photo frames company founded by early Twitter employees, is introducing its latest model, Aspen, which adds ...
April 14 (Reuters) - Danish drugmaker Novo Nordisk NOVOb.CO said on Monday several hundred counterfeit units of its diabetes drug Ozempic were being distributed outside its authorized supply chain ...
Shares of Novo Nordisk have surged more than 185% in the past five years. During the same time frame, total revenues have jumped 129% on a reported basis, while the net profit margin consistently ...
There is a long-running health crisis impacting the modern world. According to the World Health Organization, one in eight people worldwide were living with obesity as of 2022. Obesity causes ...
The popularity of Novo Nordisk's Ozempic and Wegovy has attracted competitors and created supply constraints. Novo Nordisk's next-generation weight loss drug disappointed investors in Phase III ...
Novo Nordisk may be reorganizing its early-stage ... Below these three therapy area units are other teams with names like AI and Digital Innovation, and Strategy, Portfolio, Operations and ...
In the sleepy suburb of Bagsværd, a 25-minute train ride from Denmark’s capital of Copenhagen, weight-loss drugmaker Novo Nordisk is everywhere. Street after street is filled with the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results